AIRLINK 75.30 Increased By ▲ 1.60 (2.17%)
BOP 4.94 Increased By ▲ 0.04 (0.82%)
CNERGY 4.39 Decreased By ▼ -0.13 (-2.88%)
DFML 41.18 Decreased By ▼ -3.70 (-8.24%)
DGKC 83.31 Decreased By ▼ -2.19 (-2.56%)
FCCL 21.65 Increased By ▲ 0.25 (1.17%)
FFBL 32.00 Decreased By ▼ -0.51 (-1.57%)
FFL 9.42 Decreased By ▼ -0.17 (-1.77%)
GGL 10.08 Decreased By ▼ -0.19 (-1.85%)
HASCOL 6.82 Decreased By ▼ -0.31 (-4.35%)
HBL 114.00 Decreased By ▼ -0.70 (-0.61%)
HUBC 139.10 No Change ▼ 0.00 (0%)
HUMNL 12.00 Decreased By ▼ -0.42 (-3.38%)
KEL 4.91 Decreased By ▼ -0.12 (-2.39%)
KOSM 4.36 Decreased By ▼ -0.09 (-2.02%)
MLCF 37.51 Decreased By ▼ -0.09 (-0.24%)
OGDC 132.85 Decreased By ▼ -3.95 (-2.89%)
PAEL 24.85 Decreased By ▼ -0.54 (-2.13%)
PIBTL 6.60 Decreased By ▼ -0.09 (-1.35%)
PPL 117.80 Decreased By ▼ -3.20 (-2.64%)
PRL 26.06 Decreased By ▼ -0.53 (-1.99%)
PTC 13.72 Decreased By ▼ -0.38 (-2.7%)
SEARL 57.25 Decreased By ▼ -0.05 (-0.09%)
SNGP 66.50 Decreased By ▼ -1.50 (-2.21%)
SSGC 10.24 Decreased By ▼ -0.18 (-1.73%)
TELE 8.21 Decreased By ▼ -0.24 (-2.84%)
TPLP 10.70 Decreased By ▼ -0.28 (-2.55%)
TRG 62.40 Decreased By ▼ -0.94 (-1.48%)
UNITY 27.04 Decreased By ▼ -0.01 (-0.04%)
WTL 1.35 Decreased By ▼ -0.03 (-2.17%)
BR100 7,846 Decreased By -95 (-1.2%)
BR30 25,256 Decreased By -391.8 (-1.53%)
KSE100 74,836 Decreased By -681.2 (-0.9%)
KSE30 24,004 Decreased By -273.3 (-1.13%)

imageAndrew Calabrese, a third grader was just three years old when his pancreas gave up, rendering him with the dreaded Type-1 diabetes for life.

However, his parents Heidi and Jason didn’t gave up hope, and Jason, a software engineer by profession, developed a device that could help regulate his son’s insulin levels i.e. a robotic pancreas.

According to Wall Street Journal, Jason was able to make an artificial pancreas for his son, using the OpenAPS (Open Artificial Pancreas System), which is a free online project in order to make the APS technology widely available, so that lives could be saved and the burden of Type 1 diabetes can be reduced.

As per Oddity Central, the APS was developed by a 27 year old Dana Lewis in December 2014, a Type 1 diabetic himself. The OpenAPS provides “a safety-focused reference design, a toolset, and an open source reference implementation that can be used by any individual – or any medical device manufacturer.”

imageFollowing the instructions, Jason learnt how to use an old insulin pump to control blood glucose (BG) levels, automatically, both overnight and in between meals. The software engineer added a Continuous Glucose Monitor (CGM) to provide BG data to the pump, and command it to adjust the temporary basal rates accordingly.

Andrew finally began using OpenAPS to keep in check his insulin levels, after doctor’s approval. “OpenAPS is there when I can’t be,” Jason said. “It’s cut the time Andrew spends below 80 mg/dL in half.”

“Diabetes is dangerous anyway. Insulin is dangerous. I think what we are doing is actually improving that and lowering the risk,” he added. However, Jason admitted that this solution is still subjected to pump or tubing failures, and that the insulin dosing for meals is still needed to be done manually.

Copyright Business Recorder, 2016

Comments

Comments are closed.